Last Updated on January 21, 2025 by admin
BIC-EMTAF Tablet Overview
- Active ingredient –Tenofovir Alafenamide + Emtricitabine + Bictegravir
- Strength availability – 25mg + 200mg + 50mg
- Marcketed by – Emcure
- Package 30 Tablets
BIC-EMTAF is an anti-retroviral drug containing three prominent factors is known as; Tenofovir Alafenamide Emtricitabine Bictegravir Tenofovir Alafenamide is a nucleotide transcriptase inhibitor Emtricitabine is a nucleoside reverse transcriptase inhibitor Bictegravir is an integrase inhibitor.
These are the most effective & a potent compound against HIV-1 infections, but it does not cure the infection situation it is only used for preventing & suppressing the evolution of HIV-1 infection into AIDS. In BIC-EMTAF tablets, TAF is present as a prodrug. Emtricitabine is a synthetics fluoro derivative of thiacytodone. Bictegravir is an investigational drug.
BIC-EMTAF Tablet Medicinal Benefits
One of the key benefits of the Tenofovir Alafenamide Emtricitabine Bictegravir tablet (BIC-EMTAF Tablet) is its effectiveness in suppressing the HIV-1 virus. It is known to reduce the viral load, increase CD4 cell count, and improve the overall immune system of individuals living with HIV-1 infection.
BIC-EMTAF Tablet Directions for Use
It is important to follow the prescribed dosage and directions provided by your healthcare professional. Typically, the Tenofovir Alafenamide Emtricitabine Bictegravir tablet (BIC-EMTAF Tablet) is taken orally once daily with or without food. It is recommended to take it at the same time each day to ensure consistent levels of the medication in your body.
BIC-EMTAF Tablet Storage
Proper storage of the Tenofovir Alafenamide Emtricitabine Bictegravir tablet (BIC-EMTAF Tablet) is crucial to maintain its effectiveness. It should be stored at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets.
BIC-EMTAF Tablet INDICATIONS
BIC-EMTAF is a combination tablet that contains Tenofovir Alafenamide, Emtricitabine & Bictegravir is mainly indicated for the treatment of HIV-1 infection in adult patients.
BIC-EMTAF TABLET DOSAGE
The prescribed dose of BIC-EMTAF is one tablet that should be given orally as day-to-day. Important points; before starting the treatment, the patient should be considered for the presence of hepatitis B infection or not.
BIC-EMTAF TABLET is a prescription medicine that is used to treat Human Immunodeficiency Virus-1 (HIV-1) in adults and children who weigh at least 25 kg.
Uses of BIC-EMTAF Tablet
How BIC-EMTAF Tablet works
BIC-EMTAF Tablet works by inhibiting the enzymes reverse transcriptase and integrase, thereby inhibiting the replication of viral particles in the body and treats the infection.
Interactions with other drugs:
Inform your doctor about any medications you are taking or have taken before the treatment.
BIC-EMTAF Tablet-Drug Warnings
Prior to starting the Tenofovir Alafenamide Emtricitabine Bictegravir tablet (BIC-EMTAF Tablet), it is important to inform your healthcare professional about any existing medical conditions, allergies, or medications you are currently taking. They will be able to assess whether this medication is suitable for you and if any adjustments are necessary.
BIC-EMTAF Tablet Drug Interactions
The Tenofovir Alafenamide Emtricitabine Bictegravir tablet (BIC-EMTAF Tablet) may interact with certain medications, potentially affecting their effectiveness or increasing the risk of side effects. It is important to inform your healthcare professional about all the medications you are taking, including prescription, over-the-counter, and herbal products.
BIC-EMTAF Tablet-Drug Interactions Checker List: Safety Advice
It is always advisable to consult your healthcare professional or use a reliable drug-drug interactions checker to ensure the safety and effectiveness of the Tenofovir Alafenamide Emtricitabine Bictegravir tablet (BIC-EMTAF Tablet) when taken with other medications. This will help identify any potential interactions and allow your healthcare professional to make informed decisions regarding your treatment plan.
BIC-EMTAF Tablet-Habit Forming
The Tenofovir Alafenamide Emtricitabine Bictegravir tablet (BIC-EMTAF Tablet) is not habit-forming. It is a prescription medication that should be taken as directed by your healthcare professional.
SIDE EFFECTS OF BIC-EMTAF TABLET
- Common
- Insomnia (difficulty in sleeping)
- Headache
- Diarrhea
- Nausea
- Rash
- Abdominal pain
- Fatigue
- Cough
- Back pain
HOW TO USE BIC-EMTAF TABLET
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. BIC-EMTAF Tablet may be taken with or without food, but it is better to take it at a fixed time.
SAFETY ADVICE
warnings
Alcohol CAUTION
Caution is advised when consuming alcohol with BIC-EMTAF Tablet. Please consult your doctor.
warnings
Pregnancy CAUTION
CONSULT YOUR DOCTOR
BIC-EMTAF Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
warnings
Breast feeding CAUTION
SAFE IF PRESCRIBED
BIC-EMTAF Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
warnings
Driving CAUTION
UNSAFE
BIC-EMTAF Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
warnings
Kidney CAUTION
SAFE IF PRESCRIBED
BIC-EMTAF Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of BIC-EMTAF Tablet may not be needed in these patients. Please consult your doctor.
warnings
Liver CAUTION
SAFE IF PRESCRIBED
BIC-EMTAF Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of BIC-EMTAF Tablet may not be needed in these patients. Please consult your doctor.
warnings
CHILDREN CAUTION
UNSAFE
BIC-EMTAF Tablet is not recommended for use in children and adolescents below 18 years.
Diet
There are no specific dietary restrictions associated with the Tenofovir Alafenamide Emtricitabine Bictegravir tablet (BIC-EMTAF Tablet). However, maintaining a healthy and balanced diet is always beneficial for overall health and wellbeing.
Expert Advice
WHAT IF YOU FORGET TO TAKE BIC-EMTAF TABLET?
A: If you miss a dose of BIC-EMTAF Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
- BIC-EMTAF Tablet is a combination of three medicines which slows down or stops the progression of HIV infections.
- Take it on an empty stomach, preferably at bedtime, to reduce side effects.
- Skipping doses increases the risk of treatment failure. Make sure that you take all your doses at the correct time.
- BIC-EMTAF Tablet may cause dizziness or sleepiness. Don’t drive or do anything requiring concentration until you know how it affects you.
- BIC-EMTAF Tablet can cause birth defects. Use effective contraception while taking BIC-EMTAF Tablet and 12 weeks after stopping it.
- It may cause weakening of your bones. Exercise regularly and take calcium and vitamin D supplements as suggested by your doctor.
- Your doctor may monitor your kidney and liver functions regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, darkened urine or yellowing of the eyes or skin.
- Do not stop taking BIC-EMTAF Tablet without your doctor’s advice.
- Keep BIC-EMTAF Tablet out of sight and reach of children.
Conclusion
The Tenofovir Alafenamide Emtricitabine Bictegravir tablet (BIC-EMTAF Tablet) is a valuable medication for the treatment of HIV-1 infection. It offers numerous medicinal benefits, including the suppression of the virus and improvement of the immune system. By following the prescribed dosage, storage guidelines, and consulting your healthcare professional regarding any potential drug interactions, you can effectively manage your condition and enhance your overall well-being.
BIC-EMTAF Tablet FAQs
Q: Is it safe to take BIC-EMTAF Tablet?
A: You should take BIC-EMTAF Tablet only as per your doctor’s advice.
Q: Can I get BIC-EMTAF Tablet without a prescription?
A: No, you need a doctor’s prescription to get BIC-EMTAF Tablet since it is a prescription medicine. Your doctor will prescribe it only if they judge that it would be beneficial for you.
Q: What BIC-EMTAF Tablet contains?
A: BIC-EMTAF Tablet contains salt composition of Bictegravir + Emtricitabine + Tenofovir Alafenamide (generic name).
Q: Who is the marcketed of BIC-EMTAF Tablet?
A: BIC-EMTAF Tablet is manufactured/marketed by Emcure.
Q: How to use BIC-EMTAF Tablet?
A: Take this medicine in the dose and duration as advised by your doctor.
Q: what is the BIC-EMTAF tablets price?
A: The price of BIC-EMTAF tablet is cheaper if you buy it in bulk, the last rate of BIC-EMTAF tablet is available in @2999.You Can Order From HIVHUB.IN With Free Shipping Cash On Delivery Available No Hidden Charges.
Q: How/Where to buy BIC-EMTAF Tablet?
A: It is always better to check the credential of the person/distributor before confirming your order if you are importing medicine from India. As per the legal guidelines, only patients with a valid prescription or valid drug license holder can import the product after getting proper Documentation.
Some More BIC-EMTAF Tablet FAQs
1. What is BIC-EMTAF tablet used for?
BIC-EMTAF tablet is used for the treatment of HIV-1 infection in adults and children weighing at least 25 kg. It helps to control the virus and improve the immune system.
2. When is the best time to take BIC-EMTAF tablet?
BIC-EMTAF tablet can be taken at any time of the day, with or without food. It is important to take it consistently at the same time each day to maintain even levels of the medication in your body.
3. What are the long-term side effects of BIC-EMTAF tablet?
Long-term side effects may include liver problems, changes in body fat, and potential effects on kidney function. Regular monitoring by a healthcare provider is recommended.
4. Can you provide a review of BIC-EMTAF tablet?
Many patients report that BIC-EMTAF tablet is effective in managing their HIV with minimal side effects. However, individual experiences may vary, and it is important to consult a healthcare professional for personalized advice.
5. What are the common uses of BIC-EMTAF tablet?
The primary use of BIC-EMTAF tablet is to treat HIV-1 infection. It is also used in combination with other medications for patients with specific treatment needs.
6. What is the recommended dosage of BIC-EMTAF tablet?
The recommended dosage for adults and children over 25 kg is one tablet (50 mg/200 mg/25 mg) taken once daily.
7. Is BIC-EMTAF tablet safe to use?
BIC-EMTAF tablet is generally considered safe for most patients; however, it is important to discuss your medical history and any potential allergies with your healthcare provider before starting treatment.
8. Does BIC-EMTAF tablet cure HIV infection?
No, BIC-EMTAF tablet does not cure HIV infection. It helps to control the virus and manage the condition effectively, allowing individuals to live healthier lives.
9. Is BIC-EMTAF tablet safe in pregnancy?
BIC-EMTAF tablet is generally considered safe during pregnancy, but it is important to discuss the risks and benefits with your healthcare provider.
10. Can BIC-EMTAF tablet be used on children?
Yes, BIC-EMTAF tablet can be used in children who weigh at least 25 kg, under the supervision of a healthcare provider.
11. What if I miss a dose of BIC-EMTAF tablet?
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at once.
12. Can I stop taking BIC-EMTAF tablet?
You should not stop taking BIC-EMTAF tablet without consulting your healthcare provider, as this could lead to drug resistance and worsening of your condition.
13. What are the uses of BIC-EMTAF tablet?
BIC-EMTAF tablet is used to treat HIV-1 infection, and it may also be used in specific cases of pre-exposure prophylaxis (PrEP) under medical guidance.
14. Are there alternative medications to BIC-EMTAF tablet?
Yes, there are several alternative medications for HIV treatment, including other antiretroviral drugs. Your healthcare provider can recommend alternatives based on your specific situation.
15. Can BIC-EMTAF tablet interact with other medications?
Yes, BIC-EMTAF tablet can interact with other medications. It is crucial to inform your healthcare provider about all the medications you are taking to avoid potential interactions.
16. How long does it take for BIC-EMTAF tablet to show results?
Most patients may start to see improvements in their viral load within a few weeks of starting BIC-EMTAF tablet, although individual responses can vary.
17. What precautions should be taken while using BIC-EMTAF tablet?
Patients should have regular check-ups to monitor liver function and kidney health, and should inform their doctor of any other health conditions and medications.
18. Where can I get more information about BIC-EMTAF tablet?
You can find more information about BIC-EMTAF tablet on the official website of the manufacturer, as well as from reputable health organizations like the CDC and WHO.
19. What is the success rate of BIC-EMTAF tablet in treating HIV?
BIC-EMTAF tablet has shown high efficacy rates in clinical trials, with many patients achieving viral suppression. However, individual results may vary based on adherence and other factors.
20. Can I find references for more detailed information?
Yes, you can refer to the following links for more detailed information:
– [FDA – BIC-EMTAF tablet Information] https://www.fda.gov
– [CDC – HIV Treatment Guidelines](https://www.cdc.gov/hiv/guidelines/index.html)
– [NIH – BIKTARVY (BIC-EMTAF tablet) Overview](https://aidsinfo.nih.gov)
Please consult your healthcare provider for personalized medical advice and recommendations.
References:
- KD Tripathi, Essentials of Medical Pharmacology, Antiviral drugs, 7th edition, 2013, 808.
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Antiretroviral agents and treatment of HIV infection, 12th edition, 2011, 1634-1638.
- Gilead Sciences Ltd, Electronic medicines compendium (emc), [ Revised on May 2021] [ Accessed on 11th Jan 2022], https://www.medicines.org.uk/emc/files/pil.9313.pdf
There are no reviews yet.